Given the fact that AIs and ovarian suppression are ineffectual to the carcinogenic potential of environmental estrogens, the effective mitigation of the role played by all estrogens in cancer proliferation will rely on the targeted protein degradation of nuclear estrogen receptors and GPER. The gene discussed is GPER1; the disease is cancer.